CGF and a/iPRF in oral implant bone grafting surgery

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300070107

Enrollment

Unknown

Registered

2023-04-03

Start date

2020-12-03

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Defects

Interventions

control group:No

Deproteinized bovine bone mineral group (DBBM group) :Add deproteinized bovine bone mineral (DBBM) only.

CGF group( concentrated growth factors group) :Add concentrated growth factor(CGF)

liquid concentrated growth factor together with deproteinized bovine bone mineral group(LPCGF+DBBM group):Add liquid concentrated growth factor (LPCGF) together with deproteinized bovine bone mineral

Concentrated growth factor together with deproteinized bovine bone mineral group(CGF+DBBM group):Add concentrated growth factor(CGF) together with deproteinized bovine bone mineral (DBBM).

liquid concentrated growth factor together with deproteinized bovine bone mineral together with CGF group(LPCGF+DBBM+CGF group):Add liquid concentrated growth factor (LPCGF) together with deproteiniz

Eligibility

Sex/Gender

All

Age

20 Years to 76 Years

Inclusion criteria

Inclusion criteria: Age >= 18 years; maxillary molars or premolars missing and well healed; no cysts or inflammation in the maxillary sinus on preoperative CBCT; reduced RBH and inability to place >8.5mm implants; no smoking, alcohol or other bad habits; no history of radiotherapy in the head and neck, normal preoperative blood count and glucose; no moderate, severe or uncontrolled periodontal disease with good plaque control; no systemic diseases that are not suitable for oral surgery systemic diseases.

Exclusion criteria

Exclusion criteria: Does not meet the inclusion criteria (1) Unable to understand the experimental content or withdrew in the middle of the experiment (2) Intolerant of systemic diseases (3) Those who have a history of radiation therapy and are receiving radiation therapy and immunosuppressive therapy (4) Severe periodontitis or poor oral hygiene (5) Pregnant or lactating women

Design outcomes

Primary

Measure	Time frame
Cone beam computed tomography;	—

Secondary

Measure	Time frame
Planting success rate;Aesthetic evaluation criteria;	—

Countries

China

Contacts

Public ContactXu Binting

bintingxu@hospital.cqmu.edu.cn18523868227

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026